Researcher profile

Sai Krishna Gottipati

Sai Krishna Gottipati contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2024arXiv

GLIDE-RL: Grounded Language Instruction through DEmonstration in RL

One of the final frontiers in the development of complex human - AI collaborative systems is the ability of AI agents to comprehend the natural language and perform tasks accordingly. However, training efficient Reinforcement Learning (RL) agents grounded in natural language has been a long-standing challenge due to the complexity and ambiguity of the language and sparsity of the rewards, among other factors. Several advances in reinforcement learning, curriculum learning, continual learning, language models have independently contributed to effective training of grounded agents in various environments. Leveraging these developments, we present a novel algorithm, Grounded Language Instruction through DEmonstration in RL (GLIDE-RL) that introduces a teacher-instructor-student curriculum learning framework for training an RL agent capable of following natural language instructions that can generalize to previously unseen language instructions. In this multi-agent framework, the teacher and the student agents learn simultaneously based on the student's current skill level. We further demonstrate the necessity for training the student agent with not just one, but multiple teacher agents. Experiments on a complex sparse reward environment validates the effectiveness of our proposed approach.

preprint2020arXiv

Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning

Over the last decade, there has been significant progress in the field of machine learning for de novo drug design, particularly in deep generative models. However, current generative approaches exhibit a significant challenge as they do not ensure that the proposed molecular structures can be feasibly synthesized nor do they provide the synthesis routes of the proposed small molecules, thereby seriously limiting their practical applicability. In this work, we propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design, Policy Gradient for Forward Synthesis (PGFS), that addresses this challenge by embedding the concept of synthetic accessibility directly into the de novo drug design system. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space by subjecting commercially available small molecule building blocks to valid chemical reactions at every time step of the iterative virtual multi-step synthesis process. The proposed environment for drug discovery provides a highly challenging test-bed for RL algorithms owing to the large state space and high-dimensional continuous action space with hierarchical actions. PGFS achieves state-of-the-art performance in generating structures with high QED and penalized clogP. Moreover, we validate PGFS in an in-silico proof-of-concept associated with three HIV targets. Finally, we describe how the end-to-end training conceptualized in this study represents an important paradigm in radically expanding the synthesizable chemical space and automating the drug discovery process.